Atria Wealth Solutions, Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Atria Wealth Solutions, Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$498,816
+32.8%
259,800
-0.4%
0.01%
+40.0%
Q2 2023$375,552
-32.1%
260,800
-0.9%
0.01%
-37.5%
Q1 2023$552,930
+80.8%
263,300
-2.7%
0.01%
+60.0%
Q4 2022$305,891
-32.7%
270,700
-2.9%
0.01%
-37.5%
Q3 2022$454,281
+23.1%
278,700
-1.1%
0.01%
+14.3%
Q2 2022$369,000
-19.8%
281,700
-1.4%
0.01%
-12.5%
Q1 2022$460,000285,7000.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders